EASL Clinical Practice Guidelines: management of cholestatic liver diseases.
D000328:Adult; D002648:Child; D002761:Cholangitis / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D015209:Cholangitis, Sclerosing / Q000175:diagnosis / Q000628:therapy; D002780:Cholestasis, Intrahepatic / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D003550:Cystic Fibrosis / Q000150:complications; D005260:Female; D019693:Hepatitis, Autoimmune / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007223:Infant; D008105:Liver Cirrhosis, Biliary / Q000175:diagnosis / Q000628:therapy; D008297:Male; D010024:Osteoporosis / Q000209:etiology / Q000628:therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000628:therapy; D013577:Syndrome
D007074:Immunoglobulin G